Your browser doesn't support javascript.
loading
Nanodelivery of cerebrolysin reduces pathophysiology of Parkinson's disease.
Ozkizilcik, Asya; Sharma, Aruna; Lafuente, José Vicente; Muresanu, Dafin F; Castellani, Rudy J; Nozari, Ala; Tian, Z Ryan; Mössler, Herbert; Sharma, Hari Shanker.
Afiliação
  • Ozkizilcik A; Department of Biomedical Engineering, University of Arkansas, Fayetteville, AR, United States.
  • Sharma A; International Experimental Central Nervous System Injury & Repair (IECNSIR), Department of Surgical Sciences, Anesthesiology & Intensive Care Medicine, Uppsala University Hospital, Uppsala University, Uppsala, Sweden.
  • Lafuente JV; LaNCE, Department of Neuroscience, University of the Basque Country (UPV/EHU), Leioa, Spain.
  • Muresanu DF; Department of Clinical Neurosciences, University of Medicine & Pharmacy, Cluj-Napoca, Romania; "RoNeuro" Institute for Neurological Research and Diagnostic, Cluj-Napoca, Romania.
  • Castellani RJ; Department of Pathology, University of Maryland, Baltimore, MD, United States.
  • Nozari A; Anesthesiology & Intensive Care, Massachusetts General Hospital, Boston, MA, United States.
  • Tian ZR; Department of Chemistry & Biochemistry, University of Arkansas, Fayetteville, AR, United States.
  • Mössler H; Ever NeuroPharma, Oberburgau, Austria.
  • Sharma HS; International Experimental Central Nervous System Injury & Repair (IECNSIR), Department of Surgical Sciences, Anesthesiology & Intensive Care Medicine, Uppsala University Hospital, Uppsala University, Uppsala, Sweden. Electronic address: sharma@surgsci.uu.se.
Prog Brain Res ; 245: 201-246, 2019.
Article em En | MEDLINE | ID: mdl-30961868

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Fármacos Neuroprotetores / Nanomedicina / Nanofios / Aminoácidos Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Prog Brain Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Fármacos Neuroprotetores / Nanomedicina / Nanofios / Aminoácidos Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Prog Brain Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos